766 results on '"Rassy, Elie"'
Search Results
2. Breast cancer survivors’ opinion on personalizing endocrine therapy and developing informative tools
3. New clinical trials in CUP and a novel paradigm in cancer classification
4. Forget lung, breast or prostate cancer: why tumour naming needs to change
5. Predicting tumour origin with cytology-based deep learning: hype or hope?
6. Long road towards effective HER3 targeting in breast cancer
7. Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials
8. Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead
9. Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
10. The educational contribution of the college of the European school of oncology (ESCO): A survey analysis of the first three years
11. Advances in adoptive T-cell therapy for metastatic melanoma
12. Learning by Debate: Innovative Tool in the Hematology-Oncology Fellowship Program
13. Antibody-Drug Conjugates in Prostate Cancer: Where Are we?
14. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors
15. Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer
16. Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
17. Systematic review of the CUP trials characteristics and perspectives for next-generation studies
18. Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead
19. Systematic review of fetal and placental metastases among pregnant patients with cancer
20. ESO's career development program (2002-2021): Presentation and evaluation
21. The Contribution of the European School Of Oncology Education to the Central Asian and Caucasian Regions
22. Eight-Year Experience of the Certificate of Competence and Advanced Studies Program Organized by the European School of Oncology
23. Sarcoma of unknown primary: myth or reality?
24. The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry
25. Chemotherapy in the management of periosteal osteosarcoma: A narrative review
26. Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic
27. Impact of radiation therapy on healthy tissues
28. Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy Experience
29. Melanoma of unknown primary: New perspectives for an old story
30. Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review
31. A comprehensive overview of promising biomarkers in stage II colorectal cancer
32. What can we learn from cancer of unknown primary in canine oncology?
33. Comprehensive tumor profiling-guided therapy in rare or refractory solid cancer: A feasibility study in daily clinical practice
34. A comprehensive review on the diagnosis and management of intimal sarcoma of the pulmonary artery
35. New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?
36. The role of site-specific therapy for cancers of unknown of primary: A meta-analysis
37. TRK inhibition in soft tissue sarcomas: A comprehensive review
38. Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma – A Meta-analysis
39. Progress in refining the clinical management of cancer of unknown primary in the molecular era
40. Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
41. Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?
42. Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach
43. Paraneoplastic syndromes in cancers of unknown primary: An unknown field for oncologists
44. A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma
45. Telehealth in breast cancer following the coronavirus disease 2019 pandemic
46. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary
47. A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin
48. Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment
49. The current evidence for a biomarker-based approach in cancer of unknown primary
50. Geriatric cancer trends in the Middle-East: Findings from Lebanese cancer projections until 2025
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.